Table of Content

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights


2. Assumptions and Research Methodology


3. Executive Summary: Global Pericardiocentesis Procedures Market


4. Market Overview

4.1. Introduction

4.1.1. Pericardiocentesis Procedures Introduction

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Pericardiocentesis Procedures Market Analysis and Forecast, 2017–2027

4.4.1. Market Revenue Projections (US$ Mn)


5. Key Insights

5.1. Regulatory Scenario

5.2. Overview of Large Pericardial Effusions

5.3. Reimbursement Scenario

5.4. Booming investments in private hospitals in India


6. Global Pericardiocentesis Procedures Market Analysis and Forecast, by Indication

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Market Value Forecast, by Indication, 2017–2027

6.3.1. Infections

6.3.1.1. Tuberculosis Infection

6.3.1.2. Bacterial Infection

6.3.1.3. Others

6.3.2. Malignancies

6.3.2.1. Lung Cancer

6.3.2.2. Breast Cancer

6.3.2.3. Lymphoma

6.3.2.4. Others

6.3.3. Inflammatory/Rheumatology

6.3.3.1. Rheumatoid Arthritis

6.3.3.2. Systemic Lupus Erythromatosus

6.3.3.3. Others

6.3.4. Cardiac

6.3.5. Others

6.4. Market Attractiveness Analysis, by Indication


7. Global Pericardiocentesis Procedures Market Analysis and Forecast, by End-user

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Market Value Forecast, by End-user, 2017–2027

7.3.1. Hospitals

7.3.2. Cardiac Centers

7.3.3. Others

7.4. Market Attractiveness Analysis, by End-user


8. Global Pericardiocentesis Procedures Market Analysis and Forecast, by Region

8.1. Key Findings

8.2. Market Value Forecast, by Region

8.2.1. North America

8.2.2. Europe

8.2.3. Asia Pacific

8.2.4. Latin America

8.2.5. Middle East & Africa

8.3. Market Attractiveness Analysis, by Country/Region


9. North America Global Pericardiocentesis Procedures Market Analysis and Forecast

9.1. Introduction

9.2. Key Findings

9.3. Market Value Forecast, by Indication, 2017–2027

9.3.1. Infections

9.3.1.1. Tuberculosis Infection

9.3.1.2. Bacterial Infection

9.3.1.3. Others

9.3.2. Malignancies

9.3.2.1. Lung Cancer

9.3.2.2. Breast Cancer

9.3.2.3. Lymphoma

9.3.2.4. Others

9.3.3. Inflammatory/Rheumatology

9.3.3.1. Rheumatoid Arthritis

9.3.3.2. Systemic Lupus Erythromatosus

9.3.3.3. Others

9.3.4. Cardiac

9.3.5. Others

9.4. Market Value Forecast, by End-user, 2017–2027

9.4.1. Hospitals

9.4.2. Cardiac Centers

9.4.3. Others

9.5. Market Value Forecast, by Country, 2017–2027

9.5.1. U.S.

9.5.2. Canada

9.6. Market Attractiveness Analysis

9.6.1. By Indication

9.6.2. By End-user

9.6.3. By Country


10. Europe Global Pericardiocentesis Procedures Market Analysis and Forecast

10.1. Introduction

10.2. Key Findings

10.3. Market Value Forecast, by Indication, 2017–2027

10.3.1. Infections

10.3.1.1. Tuberculosis Infection

10.3.1.2. Bacterial Infection

10.3.1.3. Others

10.3.2. Malignancies

10.3.2.1. Lung Cancer

10.3.2.2. Breast Cancer

10.3.2.3. Lymphoma

10.3.2.4. Others

10.3.3. Inflammatory/Rheumatology

10.3.3.1. Rheumatoid Arthritis

10.3.3.2. Systemic Lupus Erythromatosus

10.3.3.3. Others

10.3.4. Cardiac

10.3.5. Others

10.4. Market Value Forecast, by End-user, 2017–2027

10.4.1. Hospitals

10.4.2. Cardiac Centers

10.4.3. Others

10.5. Market Value Forecast, by Country/Sub-region, 2017–2027

10.5.1. Germany

10.5.2. U.K.

10.5.3. France

10.5.4. Italy

10.5.5. Spain

10.5.6. Rest of Europe

10.6. Market Attractiveness Analysis

10.6.1. By Indication

10.6.2. By End-user

10.6.3. By Country/Sub-region


11. Asia Pacific Global Pericardiocentesis Procedures Market Analysis and Forecast

11.1. Introduction

11.2. Key Findings

11.3. Market Value Forecast, by Indication, 2017–2027

11.3.1. Infections

11.3.1.1. Tuberculosis Infection

11.3.1.2. Bacterial Infection

11.3.1.3. Others

11.3.2. Malignancies

11.3.2.1. Lung Cancer

11.3.2.2. Breast Cancer

11.3.2.3. Lymphoma

11.3.2.4. Others

11.3.3. Inflammatory/Rheumatology

11.3.3.1. Rheumatoid Arthritis

11.3.3.2. Systemic Lupus Erythromatosus

11.3.3.3. Others

11.3.4. Cardiac

11.3.5. Others

11.4. Market Value Forecast, by End-user, 2017–2027

11.4.1. Hospitals

11.4.2. Cardiac Centers

11.4.3. Others

11.5. Market Value Forecast, by Country/Sub-region, 2017–2027

11.5.1. China

11.5.2. India

11.5.3. Japan

11.5.4. Australia & New Zealand

11.5.5. Rest of Asia Pacific

11.6. Market Attractiveness Analysis

11.6.1. By Technique

11.6.2. By End-user

11.6.3. By Country/Sub-region

12. Latin America Global Pericardiocentesis Procedures Market Analysis and Forecast

12.1. Introduction

12.2. Key Findings

12.3. Market Value Forecast, by Indication, 2017–2027

12.3.1. Infections

12.3.1.1. Tuberculosis Infection

12.3.1.2. Bacterial Infection

12.3.1.3. Others

12.3.2. Malignancies

12.3.2.1. Lung Cancer

12.3.2.2. Breast Cancer

12.3.2.3. Lymphoma

12.3.2.4. Others

12.3.3. Inflammatory/Rheumatology

12.3.3.1. Rheumatoid Arthritis

12.3.3.2. Systemic Lupus Erythromatosus

12.3.3.3. Others

12.3.4. Cardiac

12.3.5. Others

12.4. Market Value Forecast, by End-user, 2017–2027

12.4.1. Hospitals

12.4.2. Cardiac Centers

12.4.3. Others

12.5. Market Value Forecast, by Country/Sub-region, 2017–2027

12.5.1. Brazil

12.5.2. Mexico

12.5.3. Rest of Latin America

12.6. Market Attractiveness Analysis

12.6.1. By Technique

12.6.2. By End-user

12.6.3. By Country/Sub-region

13. Middle East and Africa Global Pericardiocentesis Procedures Market Analysis and Forecast

13.1. Introduction

13.2. Key Findings

13.3. Market Value Forecast, by Indication, 2017–2027

13.3.1. Infections

13.3.1.1. Tuberculosis Infection

13.3.1.2. Bacterial Infection

13.3.1.3. Others

13.3.2. Malignancies

13.3.2.1. Lung Cancer

13.3.2.2. Breast Cancer

13.3.2.3. Lymphoma

13.3.2.4. Others

13.3.3. Inflammatory/Rheumatology

13.3.3.1. Rheumatoid Arthritis

13.3.3.2. Systemic Lupus Erythromatosus

13.3.3.3. Others

13.3.4. Cardiac

13.3.5. Others

13.4. Market Value Forecast, by End-user, 2017–2027

13.4.1. Hospitals

13.4.2. Cardiac Centers

13.4.3. Others

13.5. Market Value Forecast, by Country/Sub-region, 2017–2027

13.5.1. GCC Countries

13.5.2. South Africa

13.5.3. Rest of Middle East & Africa

13.6. Market Attractiveness Analysis

13.6.1. By Technique

13.6.2. By End-user

13.6.3. By Country/Sub-region

14. Competition Landscape

14.1. Market Player - Competition Matrix (By Tier and Size of companies)

14.2. Market Share Analysis, by Company, 2018

14.3. Company Profiles

14.3.1. New York-Presbyterian Hospital/Weill Cornell Medical Center

14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.1.2. Product Portfolio

14.3.1.3. SWOT Analysis

14.3.1.4. Strategic Overview

14.3.2. Florida Hospital Orlando

14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.2.2. Product Portfolio

14.3.2.3. SWOT Analysis

14.3.2.4. Strategic Overview

14.3.3. Cleveland Clinic

14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.3.2. Product Portfolio

14.3.3.3. SWOT Analysis

14.3.3.4. Strategic Overview

14.3.4. John Hopkins Hospital

14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.4.2. Product Portfolio

14.3.4.3. SWOT Analysis

14.3.4.4. Strategic Overview

14.3.5. Saint George Hospital

14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.5.2. Product Portfolio

14.3.5.3. SWOT Analysis

14.3.5.4. Strategic Overview

14.3.6. Buddhist Tzu Chi General Hospital

14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.6.2. Product Portfolio

14.3.6.3. SWOT Analysis

14.3.6.4. Strategic Overview

14.3.7. J. W. Goethe University Hospital

14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.7.2. Product Portfolio

14.3.7.3. SWOT Analysis

14.3.7.4. Strategic Overview

14.3.8. The University of Tokyo Hospital

14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.8.2. Product Portfolio

14.3.8.3. SWOT Analysis

14.3.8.4. Strategic Overview

14.3.9. Heart Institute, University of Sao Paulo

14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.9.2. Product Portfolio

14.3.9.3. SWOT Analysis

14.3.9.4. Strategic Overview

14.3.10. Mediclinic International

14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.10.2. Product Portfolio

14.3.10.3. SWOT Analysis

14.3.10.4. Strategic Overview

14.3.11. Apollo Hospitals Enterprise Ltd

14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

14.3.11.2. Product Portfolio

14.3.11.3. SWOT Analysis

14.3.11.4. Strategic Overview



List of Figures



Figure 01: Global Pericardiocentesis Procedures Market Value (US$ Mn) and Distribution (%), by Region, 2018 and 2027

Figure 02: Global Pericardiocentesis Market Value (US$ Mn) and Volume (Number of Procedures) Forecast, 2017–2027

Figure 03: Global Pericardiocentesis Procedures Market Value Share, by Indication, 2018

Figure 04: Global Pericardiocentesis Procedures Market Value Share, by End-user, 2018

Figure 05: Global Pericardiocentesis Procedures Market Value Share, by Region, 2018

Figure 06: Global Pericardiocentesis Procedures Market Value Share Analysis, by Indication, 2018 and 2027

Figure 07: Global Pericardiocentesis Procedures Market Value (US$ Mn) and Y-o-Y Growth, by Infections, 2017–2027

Figure 08: Global Pericardiocentesis Procedures Market Value (US$ Mn) and Y-o-Y Growth, by Malignancies, 2017–2027

Figure 09: Global Pericardiocentesis Procedures Market Value (US$ Mn) and Y-o-Y Growth, by Inflammatory/ Rheumatologic, 2017–2027

Figure 10: Global Pericardiocentesis Procedures Market Value (US$ Mn) and Y-o-Y Growth, by Cardiac, 2017–2027

Figure 11: Global Pericardiocentesis Procedures Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2027

Figure 12: Global Pericardiocentesis Procedures Market Attractiveness Analysis, by Indication, 2019–2027

Figure 13: Global Pericardiocentesis Procedures Market Value Share Analysis, by End-user, 2018 and 2027

Figure 14: Global Pericardiocentesis Procedures Market Attractiveness Analysis, by End-user, 2019–2027

Figure 15: Global Pericardiocentesis Procedures Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017–2027

Figure 16: Global Pericardiocentesis Procedures Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cardiac Centers, 2017–2027

Figure 17: Global Pericardiocentesis Procedures Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 18: Global Pericardiocentesis Procedures Market Value Share Analysis, by Region, 2018 and 2027

Figure 19: Global Pericardiocentesis Procedures Market Attractiveness Analysis, by Region, 2019–2027

Figure 20: North America Pericardiocentesis Procedures Market Value (US$ Mn) and Volume (Number of Procedures) Forecast, 2017–2027

Figure 21: North America Pericardiocentesis Procedures Market Value Share Analysis, by Country, 2018 and 2027

Figure 22: North America Pericardiocentesis Procedures Market Attractiveness, by Country, 2019–2027

Figure 23: North America Pericardiocentesis Procedures Market Value Share Analysis, by Indication, 2018 and 2027

Figure 24: North America Pericardiocentesis Procedures Market Attractiveness Analysis, by Indication, 2019–2027

Figure 25: North America Pericardiocentesis Procedures Market Value Share Analysis, by End-user, 2018 and 2027

Figure 26: North America Pericardiocentesis Procedures Market Attractiveness Analysis, by End-user, 2019–2027

Figure 27: Europe Pericardiocentesis Procedures Market Value (US$ Mn) and Volume (Number of Procedure) Forecast, 2017–2027

Figure 28: Europe Pericardiocentesis Procedures Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 29: Europe Pericardiocentesis Procedures Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 30: Europe Pericardiocentesis Procedures Market Value Share Analysis, by Indication, 2018 and 2027

Figure 31: Europe Pericardiocentesis Procedures Market Attractiveness Analysis, by Indication, 2019–2027

Figure 32: Europe Pericardiocentesis Procedures Market Value Share Analysis, by End-user, 2018 and 2027

Figure 33: Europe Pericardiocentesis Procedures Market Attractiveness Analysis, by End-user, 2019–2027

Figure 34: Asia Pacific Pericardiocentesis Procedures Market Value (US$ Mn) and Volume (Number of Procedures) Forecast, 2017–2027

Figure 35: Asia Pacific Pericardiocentesis Procedures Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 36: Asia Pacific Pericardiocentesis Procedures Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 37: Asia Pacific Pericardiocentesis Procedures Market Value Share Analysis, by Indication, 2018 and 2027

Figure 38: Asia Pacific Pericardiocentesis Procedures Market Attractiveness Analysis, by Indication, 2019–2027

Figure 39: Asia Pacific Pericardiocentesis Procedures Market Value Share Analysis, by End-user, 2018 and 2027

Figure 40: Asia Pacific Pericardiocentesis Procedures Market Attractiveness Analysis, by End-user, 2019–2027

Figure 41: Latin America Pericardiocentesis Procedures Market Value (US$ Mn) and Volume (Number of procedures) Forecast, 2017–2027

Figure 42: Latin America Pericardiocentesis Procedures Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 43: Latin America Pericardiocentesis Procedures Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 44: Latin America Pericardiocentesis Procedures Market Value Share Analysis, by Indication, 2018 and 2027

Figure 45: Latin America Pericardiocentesis Procedures Market Attractiveness Analysis, by Indication, 2019–2027

Figure 46: Latin America Pericardiocentesis Procedures Market Value Share Analysis, by End-user, 2018 and 2027

Figure 47: Latin America Pericardiocentesis Procedures Market Attractiveness Analysis, by End-user, 2019–2027

Figure 48: Middle East & Africa Pericardiocentesis Procedures Market Value (US$ Mn) and Volume (Number of procedures) Forecast, 2017–2027

Figure 49: Middle East & Africa Pericardiocentesis Procedures Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 50: Middle East & Africa Pericardiocentesis Procedures Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 51: Middle East & Africa Pericardiocentesis Procedures Market Value Share Analysis, by Indication, 2018 and 2027

Figure 52: Middle East & Africa Pericardiocentesis Procedures Market Attractiveness Analysis, by Indication, 2019–2027

Figure 53: Middle East & Africa Pericardiocentesis Procedures Market Value Share Analysis, by End-user, 2018 and 2027

Figure 54: Middle East & Africa Pericardiocentesis Procedures Market Attractiveness Analysis, by End-user, 2019–2027

 

List of Tables



Table 01: Global Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Indication, 2017–2027

Table 02: Global Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Infections, 2017–2027

Table 03: Global Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Malignancies, 2017–2027

Table 04: Global Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Inflammatory/Rheumatologic, 2017–2027

Table 05: Global Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 06: Global Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 07: Global Pericardiocentesis Procedures Market Volume (Number of Procedures) Forecast, by Region, 2017–2027

Table 08: North America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 09: North America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Indication, 2017–2027

Table 10: North America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Infections, 2017–2027

Table 11: North America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Malignancies, 2017–2027

Table 12: North America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Inflammatory/Rheumatologic, 2017–2027

Table 13: North America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 14: Europe Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 15: Europe Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Indication, 2017–2027

Table 16: Europe Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Infections, 2017–2027

Table 17: Europe Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Malignancies, 2017–2027

Table 18: Europe Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Inflammatory/Rheumatologic, 2017–2027

Table 19: Europe Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 20: Asia Pacific Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 21: Asia Pacific Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Indication, 2017–2027

Table 22: Asia Pacific Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Infections, 2017–2027

Table 23: Asia Pacific Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Malignancies, 2017–2027

Table 24: Asia Pacific Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Inflammatory/Rheumatologic, 2017–2027

Table 25: Asia Pacific Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 26: Latin America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 27: Latin America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Indication, 2017–2027

Table 28: Latin America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Infections, 2017–2027

Table 29: Latin America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Malignancies, 2017–2027

Table 30: Latin America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Inflammatory/Rheumatologic, 2017–2027

Table 31: Latin America Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 32: Middle East & Africa Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 33: Middle East & Africa Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Indication, 2017–2027

Table 34: Middle East & Africa Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Infections, 2017–2027

Table 35: Middle East & Africa Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Malignancies, 2017–2027

Table 36: Middle East & Africa Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by Inflammatory/Rheumatologic, 2017–2027

Table 37: Middle East & Africa Pericardiocentesis Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2027